Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomas

F H Sarkar1, W Sakr, Y W Li

  • 1Department of Pathology, Wayne State University, School of Medicine, Detroit, MI 48201.

The Prostate
|January 1, 1992
PubMed

Insights

Retinoblastoma (RB) gene alterations, including promoter deletions and exon 21 deletions, are not associated with typical prostate adenocarcinoma. These specific RB gene changes were not found in most prostate cancer tissues studied.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The retinoblastoma tumor suppressor gene (RB gene) is crucial in preventing cancer development.
  • RB gene dysfunction, through deletions or mutations, is implicated in various human cancers.
  • Previous studies suggested RB gene alterations in prostate cancer, including promoter and exon deletions.

Purpose of the Study:

  • To investigate the association of RB gene promoter alterations and exon 21 deletions with prostate adenocarcinoma.
  • To determine if specific RB gene modifications are present in prostate cancer tissues and cell lines.

Main Methods:

  • Polymerase chain reaction (PCR) was used to analyze RNA for short-sized mRNA transcripts (exon 21 alterations).
  • DNA-PCR was employed to detect RB promoter deletions in prostate cancer specimens.
  • Total RNA and DNA were extracted from prostate tissue samples and the DU 145 cell line.

Main Results:

  • No evidence of aberrant short-sized mRNA (exon 21 alterations) was found in the 10 prostate tissue specimens.
  • The DU 145 prostate cancer cell line confirmed the presence of the short-sized mRNA transcript.
  • No RB promoter deletions were detected in the DNA of 23 prostate adenocarcinomas or one small cell carcinoma.

Conclusions:

  • Neither RB promoter alterations nor exon 21 deletions are associated with typical prostate adenocarcinoma.
  • The findings suggest these specific RB gene aberrations are not common drivers in the development of this cancer type.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...